Silvio Bicciato

Has grant

Professor

University of Modena and Reggio Emilia

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Silvio Bicciato is a Professor at the University of Modena and Reggio Emilia, Italy. His recent research focuses on cancer biology, specifically inflammatory responses in breast cancer, the role of neutrophils in lung cancer, and the mechanisms of cancer-induced myelopoiesis. Additionally, he explores the implications of artificial intelligence in healthcare and studies gene expression in response to loss-of-function mutations. His work contributes to understanding the complexities of tumor microenvironments and potential therapeutic strategies.

Recent Grants

Grant: Close

Approccio integrato di biologia sistemica per la ricostruzione dei processi di segnalazione molecolari e di attivazione monocitaria/macrofagica in risposta a stimoli infiammatori in condizioni fisiologiche mediante tecnologie omiche.

Open Date: 2007-01-01

Close Date: 2009-01-01

Grant: Close

La risposta immunitaria verso il carcinoma prostatico basi molecolari per nuove strategie terapeutiche

Open Date: 2005-01-01

Close Date: 2007-01-01

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (17)

Thomas Liebig

Technische Universität Dortmund

GERMANY

Silvio Bicciato

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis

YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS-STING.

CXCL5-mediated accumulation of mature neutrophils in lung cancer tissues impairs the differentiation program of anticancer CD8 T cells and limits the efficacy of checkpoint inhibitors

CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor

ETV7 regulates breast cancer stem-like cell features by repressing IFN-response genes

Artificial Intelligence for Hospital Health Care: Application Cases and Answers to Challenges in European Hospitals

The Genome-Wide Impact of <i>Nipblb</i> Loss-of-Function on Zebrafish Gene Expression

High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro

Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties

Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapy

Collaborators (17)

Thomas Liebig

Donald Weed

Dilay Celebi

Alessandra BISIO

Dimitrios Gunopulos

Sabato Fusco

Jani Saarela

Jean Quinn

MICHELANGELO CORDENONSI

Mattia Barbareschi

Hanna Lucie Martens

Anna Pistocchi

Yari Ciribilli

Tan Ince

Anna Citron

Milla Immonen

Mattia Forcato

Make your next move.